Cupid (CUPID) H1 FY27: Sales Up 137%, FY27 Guidance Raised to ₹880 Cr
Cupid Limited (CUPID) - Share price: ₹366 (screener.in, 21 November 2026) - Market cap: ₹49,168 crore - P/E: 290x on the last 12 months' profit (screener.in); about 179x the company's own FY27 profit guidance of ₹275 crore - ROCE: 33.9% (screener.in)
Cupid (CUPID) H1 FY27 results: sales rose 137% to ₹342.58 crore and FY27 sales guidance was raised to ₹880 crore.
Cupid makes male and female condoms, lubricants and rapid diagnostic test kits for governments, UN agencies and aid groups, and sells seven consumer brands in India. It was incorporated in 1993 in Sinnar, Maharashtra, and has been listed on the BSE since 1995 and the NSE since 2016. This article uses the company's H1 FY27 investor presentation, filed on 11 November 2026. All figures are consolidated.
Cupid H1 FY27 results
₹ crore Q2 FY27 Q2 FY26 Change H1 FY27 H1 FY26 Change --------------------- Sales (revenue from operations) 187.86 84.45 +122% 342.58 144.25 +137% EBITDA 54.77 28.41 +93% 114.83 44.89 +156% Profit after tax 56.22 24.13 +133% 100.37 39.14 +156%
- EBITDA margin was 33.5% in H1 FY27, against 31.1% in H1 FY26 and 21.0% in H1 FY25. - Profit margin was 29.3% in H1 FY27. - EBITDA in Q2 (₹54.77 crore) was lower than in Q1 (₹60.06 crore), even though sales grew 21% from Q1. Raw material cost rose faster than sales. - Export prices were raised by at least 10%, according to the presentation.
How much of Cupid's profit comes from other income?
Other income was ₹21.11 crore in Q2 FY27 against ₹2.27 crore in Q1. It was ₹23.37 crore for the half year. The presentation does not say what it is made of. Profit before tax in Q2 was ₹72.89 crore, so other income was about 29% of it. EBITDA in this presentation excludes other income. Profit after tax includes it. Read the profit growth with this in mind.
Cupid FY27 to FY29 guidance: is the growth visible?
The company gave a three-year outlook in November 2026. All sales figures are minimums. FY28 and FY29 profit figures are approximate.
₹ crore FY26 actual FY27 FY28 FY29 --------------- Sales 357.71 880+ 1,305+ 1,950+ Net profit 108.23 275+ ~390 ~605
- The FY27 sales guidance has been raised four times: ₹600 crore (original), ₹660 crore+, ₹725 to 750 crore (7 August 2026), ₹800 crore+ (30 September 2026) and ₹880 crore+ (November 2026). Profit guidance moved from ₹180 crore to ₹275 crore+. - H1 FY27 delivered 42% of the sales guidance and 36% of the profit guidance. The company says this implies a second half with total income of at least ₹514 crore and profit of at least ₹175 crore. - Track record: for FY26 the company guided ₹335 crore of sales and ₹100 crore of profit, and reported ₹357.71 crore and ₹108.23 crore.
Cupid growth drivers: Palava plant, V2 Retail and Style Baazar
Palava plant (capacity expansion). The new plant in Palava, Maharashtra, is due in Q3 FY27. It adds 770 million male condoms and 75 million female condoms a year. Capacity at Sinnar today is 480 million male and 52 million female condoms a year.
Capacity per year Sinnar today After Palava --------- Male condoms 480 million about 1.25 billion Female condoms 52 million about 125 million Rapid test kits per day about 4 lakh about 8 lakh (target end-2027)
Retail partners. - V2 Retail: an exclusive 400 sq. ft. Cupid space in each of 425+ stores, live across the network by mid-December 2026. The company expects about ₹400 crore of sales from it in the next 12 months. - Style Baazar (Baazar Style Retail): 290+ stores, targeted to pass 500 in two to three years. The company expects about ₹200 crore of sales in FY27. Cupid committed ₹331.53 crore to it through 1.01 crore convertible warrants. 45 lakh warrants have been converted and 56 lakh are pending. ₹193.67 crore has been deployed so far. - Domestic network: 1,850+ distributors, 75+ super stockists and more than 2 lakh retail outlets. The company wants 4,000+ modern trade stores in FY27, from 2,934+ listed today.
Exports and institutional supply. - Exports were ₹112.73 crore in H1 FY27 (33.4% of sales): male condoms ₹74.39 crore, female condoms ₹23.99 crore, lubricants, test kits and FMCG ₹14.35 crore. - It is the first company in the world with WHO and UNFPA prequalification for both male and female condoms. It serves 125+ countries. - South Africa 2025 to 2030 programme: 23.4 million female condoms a year (59% of the allocation) and about 153 million male condoms a year, worth about US$12.98 million a year. Supply began in December 2025. A long-term supply agreement with PFSCM (a global health supply group) began in Q1 FY27. - A proposed South Africa venture (Cupid up to 49%, a local partner at least 51%) and a proposed wholly-owned West Bengal plant are at the "in-principle" stage.
Cupid financial history: FY22 to FY26
₹ crore FY24 FY25 FY26 ------------ Sales 171.09 183.52 357.71 EBITDA 50.10 41.73 116.70 EBITDA margin 29.3% 22.7% 32.6% Profit after tax 39.85 40.89 108.23 Total equity 301.29 342.19 450.81
Over FY22 to FY26 the company says sales grew at 28.1% a year, EBITDA at 50.1% and profit at 58.2%. ROE was 24.0% and ROCE 22.1% in FY26. Debt to equity was 0.11 times and interest cover 51.8 times.
Cupid balance sheet: debt, receivables and cash
- Cash and bank balances were ₹186.45 crore at March 2026. Borrowings were ₹51.0 crore (₹12.17 crore long term and ₹38.81 crore short term). - Trade receivables were ₹100.79 crore at March 2026, against ₹67.03 crore a year earlier. That is about 28% of FY26 sales (roughly 103 days, computed here from the deck's figures). A year earlier it was about 37% of sales. - Inventories were ₹70.04 crore, up from ₹41.67 crore. - Trade payables were ₹30.53 crore, up from ₹1.25 crore. - Fixed assets were ₹92.52 crore against total assets of ₹553.22 crore. Investments (non-current) were ₹74.65 crore. - The presentation does not give a cash flow statement. Whether profit is turning into cash is not shown in it. - Management says it will make the company debt-free.
Who owns Cupid shares
30 September 2026 Holding ------ Promoter and promoter group 47.69% (46.03% at 31 March 2026) Public 46.42% Foreign institutions (FII) 4.69% Domestic institutions (DII) 1.20%
The promoter group has cut its pledge to a negligible level. In 2023, Aditya Kumar Halwasiya and Columbia Petro Chem acquired 41.84% of the company. Mr Halwasiya is Chairman and Managing Director. The presentation says he has a global finance and investment background and studied at Fordham University in New York. Six of the eight directors are independent.
How the valuation of Cupid compares
Company Price P/E Market cap (₹ crore) ROCE --------------- Cupid ₹366 290x 49,168 33.9% Honasa Consumer ₹525 59.9x 17,143 19.2% Godrej Consumer ₹920 44.3x 94,107 18.8% Colgate-Palmolive ₹1,760 34.6x 47,869 108.0% Dabur India ₹393 34.2x 69,739 20.3%
Source: screener.in peer table, 21 November 2026. These are the peers screener.in lists. None of them makes condoms or test kits, so this is only a rough guide.
Cupid's profit is growing much faster than these peers, which grew quarterly profit by 4% to 86%. Its P/E is also about five to eight times higher. The share price already assumes that the FY27 to FY29 guidance is met.
Industry size
The presentation quotes outside estimates, which the company says it does not adopt.
- Global condom market: US$14.8 billion in 2026 (Grand View Research), expected to reach US$27.0 billion by 2033, a 9.0% yearly growth rate. - India condom market: US$435.5 million in 2025, expected to reach US$811.0 million in 2034 (IMARC Group). - India rapid test (IVD) market: US$5.6 billion in 2025, expected to reach US$10.6 billion in 2034 (IMARC Group). - India FMCG market: US$289.1 billion in 2025, expected to reach US$642.9 billion by 2030 (IBEF).
Cupid's other plans (management's own statements)
These are management's forward-looking statements. They are not facts and not promises.
- Guidance: FY27 sales at least ₹880 crore and profit at least ₹275 crore. FY28 sales at least ₹1,305 crore and profit about ₹390 crore. FY29 sales at least ₹1,950 crore and profit about ₹605 crore. H2 FY27 expected to be the strongest half ever. - Palava: commissioning targeted for Q3 FY27. - Retail: V2 Retail live in all 425+ stores by mid-December 2026; Style Baazar to pass 500 stores in two to three years; 4,000+ modern trade stores in FY27. - Nitrile female condom: a latex-free product that the company says sells at 25% to 35% higher prices than latex. Production started in March 2026. - Diagnostics: 15 kits in production, 4 with CE (EU IVDR) certification. Three new kits in development. Large state government orders expected. Test kits are available to 120+ ESIC hospitals through the GeM portal. - Investments: a further US$5 million in GII Healthcare Investment (July 2026), a GCC healthcare platform with more than US$3.5 billion under management. - International footprint: about 35% expansion targeted. - Debt: management says it will make the company debt-free.
The thing to watch The guidance asks for sales to rise 2.5 times in FY27 and 5.5 times by FY29 from the FY26 level, at a P/E of 290. Palava starting on time in Q3 and V2 Retail sales showing up in the numbers are the two tests to follow.
Risks for Cupid shareholders
- Valuation: the P/E of 290 leaves little room for a miss against guidance. - Other income: a large and unexplained part of Q2 profit. - Margin: Q2 EBITDA fell from Q1 as raw material cost rose faster than sales. - Exports depend on government and UN tenders, and tender timing can move quarterly results. - Execution: the Palava plant, the V2 Retail rollout and the new business lines (test kits, beauty and home products) are all new for the company. - Retail partners: the ₹200 crore and ₹400 crore expectations depend on partner stores selling Cupid products. - Commitment of ₹331.53 crore to Baazar Style Retail, a retailer outside Cupid's core business. - The presentation says some of its images are AI-generated.
Note: I am not a SEBI-registered investment advisor. This article is for educational purposes only and is not investment advice. Please consult a registered financial advisor before making investment decisions.
Sources
- https://nsearchives.nseindia.com/corporate/CUPID11112026203934SEIntimationInvestorPresentationQ2H1FY27.pdf